Diagnostic Development Services for Cardiovascular Diseases

Cardiovascular disease is the leading cause of disease and death in the world, and in vitro diagnostics can help reduce the risk associated with the disease and accelerate drug development for cardiovascular disease. With depth-end technology and an experienced research team, Ace Therapeutics provides customized in vitro diagnostic R&D services to help clients get more in-depth and effective research solutions.

Common In Vitro Diagnostic Methods for Cardiovascular Diseases

In vitro diagnostics (IVD) is a segment of medical devices that includes reagents, diagnostic test products, instruments and related items provided to clinical and research laboratories. It refers to testing designed to identify cardiovascular disease states in vitro through samples such as body fluids and tissue samples.

• Biomarker Diagnostic Methods
  Biomarker diagnostic methods refer to methods that quickly help diagnose cardiovascular disease by measuring a number of biomarkers associated with cardiovascular disease, and are one of the most common and important IVD methods used in clinical practice.
• Pathology Diagnostic Methods
  Pathologic diagnosis is usually the final diagnosis of cardiovascular disease, and therefore is highly authoritative and can provide important information for clinical practice.
• Imaging Diagnostic Methods
  Medical imaging is also an important branch of cardiovascular disease diagnostic methods, which can obtain information about the inside of an animal's body through various imaging technologies.

Fig. 1 Diagnosis settings of cardiovascular diseases. (Shi C, et al., 2020)

As a professional service provider, Ace Therapeutics can offer integrated development services for multi-stage and customized diagnostic programs to meet your team's needs.

Ace Therapeutics is a contract research organization in the field of cardiovascular disease dedicated to providing researchers with custom diagnostic methodology and diagnostic reagent development services to help clients obtain more in-depth and effective solutions for cardiovascular disease research. If you are interested in our services, please don't hesitate to contact us.

1. Shi, C.; et al. Nanoscale Technologies in Highly Sensitive Diagnosis of Cardiovascular Diseases. Front Bioeng Biotechnol. 2020, 8:531.